Other features of breast cancer, apart from low TILs, include a lack of tumor antigenicity, dysregulation of the WNT-β-catenin pathway, the loss of phosphatase and tensin homolog (PTEN) and p53 and deletional mutations in the JAK1/2-STAT signaling pathway [126]. This evidence concerns the gene PTEN and breast cancer.